Difference between revisions of "CD56"
Jump to navigation
Jump to search
Line 2: | Line 2: | ||
==Positive== | ==Positive== | ||
===Carcinomas=== | |||
*[[Neuroendocrine carcinoma]]. | *[[Neuroendocrine carcinoma]]. | ||
*[[Small cell carcinoma]]. | *[[Small cell carcinoma]]. | ||
*[[Merkel cell carcinoma]].<ref name=pmid12727026>{{Cite journal | last1 = Kurokawa | first1 = M. | last2 = Nabeshima | first2 = K. | last3 = Akiyama | first3 = Y. | last4 = Maeda | first4 = S. | last5 = Nishida | first5 = T. | last6 = Nakayama | first6 = F. | last7 = Amano | first7 = M. | last8 = Ogata | first8 = K. | last9 = Setoyama | first9 = M. | title = CD56: a useful marker for diagnosing Merkel cell carcinoma. | journal = J Dermatol Sci | volume = 31 | issue = 3 | pages = 219-24 | month = May | year = 2003 | doi = | PMID = 12727026 }}</ref> | *[[Merkel cell carcinoma]].<ref name=pmid12727026>{{Cite journal | last1 = Kurokawa | first1 = M. | last2 = Nabeshima | first2 = K. | last3 = Akiyama | first3 = Y. | last4 = Maeda | first4 = S. | last5 = Nishida | first5 = T. | last6 = Nakayama | first6 = F. | last7 = Amano | first7 = M. | last8 = Ogata | first8 = K. | last9 = Setoyama | first9 = M. | title = CD56: a useful marker for diagnosing Merkel cell carcinoma. | journal = J Dermatol Sci | volume = 31 | issue = 3 | pages = 219-24 | month = May | year = 2003 | doi = | PMID = 12727026 }}</ref> | ||
===Others=== | |||
*[[Follicular dendritic cell sarcoma]]. | *[[Follicular dendritic cell sarcoma]]. | ||
*[[Acute myeloid leukemia]].<ref name=nordiqc>URL: [http://www.nordiqc.org/Epitopes/CD56/CD56.htm http://www.nordiqc.org/Epitopes/CD56/CD56.htm]. Accessed on: September 13, 2014.</ref> | *[[Acute myeloid leukemia]].<ref name=nordiqc>URL: [http://www.nordiqc.org/Epitopes/CD56/CD56.htm http://www.nordiqc.org/Epitopes/CD56/CD56.htm]. Accessed on: September 13, 2014.</ref> | ||
*[[Chronic myeloid leukemia]].<ref name=nordiqc/> | *[[Chronic myeloid leukemia]].<ref name=nordiqc/> | ||
*[[Extranodal natural kill lymphoma]]. | |||
==See also== | ==See also== | ||
*[[Immunohistochemistry]]. | *[[Immunohistochemistry]]. |
Revision as of 08:09, 13 September 2014
CD56 is a commonly available immunostain that is seen in a number of tumours. It is a sensitive marker of neuroendocrine differentiation.
Positive
Carcinomas
Others
- Follicular dendritic cell sarcoma.
- Acute myeloid leukemia.[2]
- Chronic myeloid leukemia.[2]
- Extranodal natural kill lymphoma.
See also
References
- ↑ Kurokawa, M.; Nabeshima, K.; Akiyama, Y.; Maeda, S.; Nishida, T.; Nakayama, F.; Amano, M.; Ogata, K. et al. (May 2003). "CD56: a useful marker for diagnosing Merkel cell carcinoma.". J Dermatol Sci 31 (3): 219-24. PMID 12727026.
- ↑ 2.0 2.1 URL: http://www.nordiqc.org/Epitopes/CD56/CD56.htm. Accessed on: September 13, 2014.